X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10366) 10366
Publication (696) 696
Book Review (203) 203
Book / eBook (114) 114
Book Chapter (74) 74
Magazine Article (42) 42
Newsletter (31) 31
Conference Proceeding (17) 17
Dissertation (9) 9
Newspaper Article (5) 5
Trade Publication Article (5) 5
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7274) 7274
index medicus (4990) 4990
warfarin (3725) 3725
administration, oral (3690) 3690
female (3603) 3603
male (3457) 3457
anticoagulants - administration & dosage (3072) 3072
anticoagulants (3049) 3049
aged (2930) 2930
anticoagulants - therapeutic use (2841) 2841
atrial fibrillation (2754) 2754
middle aged (2481) 2481
oral anticoagulation (2307) 2307
anticoagulants - adverse effects (2239) 2239
risk factors (2130) 2130
stroke (2013) 2013
cardiac & cardiovascular systems (1973) 1973
hematology (1809) 1809
peripheral vascular disease (1709) 1709
anticoagulation (1580) 1580
treatment outcome (1567) 1567
atrial fibrillation - drug therapy (1541) 1541
oral anticoagulants (1431) 1431
adult (1427) 1427
management (1412) 1412
aged, 80 and over (1404) 1404
dabigatran (1399) 1399
thromboembolism (1393) 1393
therapy (1372) 1372
international normalized ratio (1333) 1333
prevention (1287) 1287
hemorrhage - chemically induced (1283) 1283
atrial-fibrillation (1258) 1258
risk (1256) 1256
stroke - prevention & control (1248) 1248
rivaroxaban (1207) 1207
venous thromboembolism (1180) 1180
medicine, general & internal (1176) 1176
atrial fibrillation - complications (1168) 1168
warfarin - therapeutic use (1073) 1073
warfarin - administration & dosage (1022) 1022
thrombosis (965) 965
pharmacology & pharmacy (921) 921
retrospective studies (881) 881
stroke prevention (879) 879
warfarin - adverse effects (844) 844
antithrombotic therapy (842) 842
time factors (815) 815
care and treatment (807) 807
thromboembolism - prevention & control (794) 794
bleeding (790) 790
surgery (749) 749
apixaban (740) 740
risk assessment (739) 739
stroke - etiology (739) 739
abridged index medicus (727) 727
vitamin k - antagonists & inhibitors (699) 699
prospective studies (697) 697
oral anticoagulant-therapy (687) 687
aspirin (686) 686
patients (679) 679
medicine & public health (678) 678
drug therapy (672) 672
cardiac arrhythmia (647) 647
analysis (631) 631
cardiology (631) 631
blood coagulation - drug effects (629) 629
hemorrhage (623) 623
mortality (621) 621
safety (621) 621
follow-up studies (595) 595
deep-vein thrombosis (571) 571
molecular-weight heparin (570) 570
direct oral anticoagulants (568) 568
dosage and administration (553) 553
metaanalysis (546) 546
risk-factors (540) 540
research (509) 509
health aspects (504) 504
dose-response relationship, drug (459) 459
internal medicine (454) 454
guidelines (442) 442
complications (441) 441
incidence (437) 437
prothrombin time (436) 436
fibrillation (415) 415
drug administration schedule (413) 413
adolescent (407) 407
bleeding complications (406) 406
recurrence (401) 401
efficacy (394) 394
practice guidelines as topic (393) 393
anticoagulants - pharmacology (392) 392
oral anticoagulant (389) 389
clinical trials (386) 386
cardiovascular (385) 385
venous thromboembolism - drug therapy (384) 384
thrombin (383) 383
outcomes (381) 381
thromboembolism - etiology (380) 380
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (40) 40
Dentistry (Harry R Abbott) - Stacks (30) 30
Gerstein Science - Stacks (28) 28
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (23) 23
Dentistry (Harry R Abbott) - Withdrawn (16) 16
Dentistry (Harry R Abbott) - Circulation Desk (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Scarborough Hospital - Birchmount (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - May be requested (1) 1
Dentistry (Harry R Abbott) - Searching (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Online Resources - Online (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9470) 9470
German (460) 460
Spanish (235) 235
French (225) 225
Portuguese (52) 52
Italian (35) 35
Russian (35) 35
Japanese (33) 33
Polish (22) 22
Korean (11) 11
Hungarian (9) 9
Turkish (8) 8
Chinese (6) 6
Dutch (6) 6
Norwegian (6) 6
Czech (5) 5
Arabic (4) 4
Hebrew (4) 4
Danish (2) 2
Finnish (2) 2
Romanian (2) 2
Serbian (2) 2
Croatian (1) 1
Georgian (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 06/2012, Volume 107, Issue 6, pp. 1053 - 1065
Journal Article
Circulation, ISSN 0009-7322, 11/2012, Volume 126, Issue 19, pp. 2309 - 2316
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation. Early detection of atrial fibrillation and subsequent... 
Cardiovascular | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | WARFARIN | CLINICAL-IMPLICATIONS | AMERICAN-COLLEGE | CARDIAC MONITOR | RISK | OPEN-LABEL | TEMPORAL RELATIONSHIP | ISCHEMIC-STROKE | Prospective Studies | Follow-Up Studies | Humans | Male | Thiazoles - administration & dosage | Atrial Fibrillation - physiopathology | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Time Factors | Female | Stroke - epidemiology | Vitamin K | Heart Rate | Stroke - prevention & control | Pyridines - administration & dosage | Survival Rate - trends | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Europe - epidemiology | Treatment Outcome | Disease-Free Survival | Stroke - etiology | Atrial Fibrillation - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Stroke patients | Atrial fibrillation | Cardiac patients | Implants, Artificial | Prosthesis | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Coagulation | Strokes | Patients | Bleeding | Risk factors | Vitamins | Artifacts | Fibrillation | Ischemia | Defibrillators | Pacemakers | Safety engineering | Electrocardiography | Heart diseases | Trial Design
Journal Article
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, ISSN 2193-6218, 05/2013, Volume 108, Issue 4, pp. 325 - 334
Anticoagulant drugs belong to the group of antithrombotic agents and are successfully used in the prophylaxis and treatment of thromboembolic disorders. The... 
Pulmonary embolism | Blood coagulation | MEDICINE, GENERAL & INTERNAL | DIRECT THROMBIN | DABIGATRAN | MANAGEMENT | WARFARIN | INHIBITORS | Antikoagulant | Thrombosis | Arrhythmias | Recombinant Proteins - therapeutic use | Pulmonary Embolism - prevention & control | Heparinoids - adverse effects | Factor Xa Inhibitors | Humans | Postoperative Complications - prevention & control | Heparin - therapeutic use | Secondary Prevention | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Vitamin K - antagonists & inhibitors | Pipecolic Acids - adverse effects | Thromboembolism - prevention & control | Orthopedic Procedures | Pipecolic Acids - therapeutic use | Heparinoids - therapeutic use | Venous Thrombosis - prevention & control | Thromboembolism - drug therapy | Postoperative Complications - drug therapy | Venous Thrombosis - drug therapy | Administration, Oral | Antithrombins - therapeutic use | Risk Factors | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Antithrombins - adverse effects | Hirudins - adverse effects | Blood Coagulation Tests | Pulmonary Embolism - drug therapy | Arrhythmias, Cardiac - complications | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced | Infusions, Intravenous
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9813, pp. 322 - 334
Journal Article
Circulation, ISSN 0009-7322, 02/2015, Volume 131, Issue 5, pp. 488 - 494
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 3, pp. 625 - 632
In patients with atrial fibrillation (AF) who require interruption of dabigatran or warfarin for an elective surgery/procedure, the risks and benefits of... 
Warfarin | Dabigatran | Bridging anticoagulation | Surgery | PREDICTING STROKE | MANAGEMENT | ORAL ANTICOAGULATION | RISK | CLASSIFICATION | OPEN-LABEL | I TREAT | warfarin | ATRIAL-FIBRILLATION | THERAPY | ETEXILATE | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | surgery | Perioperative Care | Multivariate Analysis | Dabigatran - adverse effects | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Postoperative Hemorrhage - prevention & control | Humans | Middle Aged | Warfarin - adverse effects | Male | Warfarin - administration & dosage | Time Factors | Adult | Female | Retrospective Studies | Atrial Fibrillation - diagnosis | Odds Ratio | Surgical Procedures, Operative - adverse effects | Blood Loss, Surgical - prevention & control | Stroke - prevention & control | Drug Administration Schedule | Risk Assessment | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | Proportional Hazards Models | Logistic Models | Treatment Outcome | Anticoagulants - adverse effects | Randomized Controlled Trials as Topic | Postoperative Hemorrhage - etiology | Propensity Score | Stroke - etiology | Aged | Elective Surgical Procedures | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 120, Issue 5, pp. 792 - 796
Abstract In the ENSURE-AF study (NCT 02072434), edoxaban was compared to enoxaparin–warfarin in 2199 patients undergoing electrical cardioversion of... 
Cardiovascular | STROKE | THERAPEUTIC RANGE | CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT | QUALITY ANTICOAGULATION | PREDICT | RISK | SAME-TT2R2 SCORE | TIME | OUTCOMES | SPORTIF TRIALS | Single-Blind Method | Stroke - prevention & control | Prospective Studies | Pyridines - administration & dosage | Anticoagulants - administration & dosage | Follow-Up Studies | Atrial Fibrillation - therapy | Humans | Middle Aged | Atrial Fibrillation - complications | Electric Countershock | Male | Thiazoles - administration & dosage | Treatment Outcome | Warfarin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Enoxaparin - administration & dosage | Stroke - etiology | Female | Drug Therapy, Combination | Stroke (Disease) | Hypertension | Care and treatment | Analysis | Atrial fibrillation | Anticoagulants (Medicine) | Electric countershock | Smoking | Myocardial infarction | Heart | Drugs | Cardiac arrhythmia | Transient ischemic attack | Renal function | Liver | Medical services | Alcohol | Congestive heart failure | Bleeding | Confidence intervals | Ratios | Randomization | Fibrillation | Ischemia | Stratigraphy | Thromboembolism | Drug dosages | Age | Vitamin K | Creatinine | Anticoagulants | Cerebral infarction | Stroke | Warfarin | Kidneys | Diabetes mellitus | Regression analysis | Patients | Tobacco | Infarction | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article